Loading company details...
Beta
Latest Form 4 (Oct 9, 2026): Chris Degnan (Chief Financial Officer): Exercise/Conversion of 4,483 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Chris Degnan, Chief Financial Officer | Exercise/Conversion | 4,483 | n/a |
| Sep 9, 2026 | Mark Schoenberg, Chief Medical Officer | Exercise/Conversion | 1,667 | n/a |
| Sep 9, 2026 | Jason Drew Smith, General Counsel | Exercise/Conversion | 3,334 | n/a |
| Aug 28, 2026 | James A. Robinson Jr. | Exercise/Conversion | 2,000 | n/a |
| Aug 24, 2026 | Mark Schoenberg, Chief Medical Officer | Sale | 60,677 | $2.85M |
| Jul 10, 2026 | Mark Schoenberg, Chief Medical Officer | Sale | 10,000 | $400.0K |
| Jun 24, 2026 | Mark Schoenberg, Chief Medical Officer | Sale | 10,000 | $350.1K |
| Jun 24, 2026 | Daniel George Wildman | Grant/Award | 10,000 | n/a |
| Jun 24, 2026 | James A. Robinson Jr. | Grant/Award | 10,000 | n/a |
| Jun 24, 2026 | Stuart Holden | Grant/Award | 20,000 | n/a |